Breakthrough Medicine for Multiple Sclerosis

Convelo Therapeutics is developing a new class of medicines that unlock the regenerative capacity of the central nervous system.

Brain+on+Fire+02.jpg

Technology

Convelo scientists have developed an innovative platform to identify novel remyelinating therapeutics.

Naive_ON_4_Chi_20nm%2BIG%2BBW.jpg